Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh · Delayed Price · Currency is BDT 69.40
0.00 (0.00%)
At close: Aug 13, 2026
Navana Pharmaceuticals Market Cap
Navana Pharmaceuticals has a market cap or net worth of 7.45 billion as of August 14, 2026. Its market cap has increased by 26.87% in one year.
Market Cap
7.45B
Enterprise Value
11.10B
Revenue
10.57B
Ranking
n/a
PE Ratio
12.38
Stock Price
69.40
ChartMarket Cap Chart
Since October 18, 2022, Navana Pharmaceuticals's market cap has increased from 2.84B to 7.45B, an increase of 162.88%. That is a compound annual growth rate of 28.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 7.45B | 33.72% |
| Dec 30, 2025 | 5.57B | 6.79% |
| Dec 30, 2024 | 5.22B | -42.42% |
| Dec 28, 2023 | 9.07B | 7.79% |
| Dec 29, 2022 | 8.41B | 196.59% |
| Oct 18, 2022 | 2.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beacon Pharmaceuticals | 24.76B |
| The ACME Laboratories | 17.61B |
| Asiatic Laboratories | 14.34B |
| The IBN SINA Pharmaceutical Industry | 10.07B |
| Orion Pharma | 6.69B |
| Techno Drugs | 5.97B |
| Indo-Bangla Pharmaceuticals | 2.25B |
| Silva Pharmaceuticals | 2.21B |